Fulcrum Therapeutics Agrees to Sell HbF Assets for About $7 Million
Fulcrum Therapeutics agreed to sell its early-stage fetal hemoglobin assets for approximately $7.0 million in cash.
Related stories
Novelis Agrees to Sell Two China Units for $265 Million
Hindalco said its US-based subsidiary Novelis agreed to sell two Chinese subsidiaries for about $265 million. The proposed sale includes the subsidiary operating Novelis's automoti
M impact | MNA | Nov 15, 2026, 11:55 AM UTC
Novelis Agrees to Sell Its China Aluminum Subsidiaries
M impact | MNA | Nov 15, 2026, 05:39 AM UTC
Hindalco's Novelis Agrees to Sell China Aluminum Subsidiaries
M impact | MNA | Nov 15, 2026, 05:37 AM UTC
Centrica and Equinor Advance to Next Round of Uniper Sale
Centrica and Equinor are in the next round of Germany’s Uniper sale, Bloomberg News reports.
M impact | MNA | Nov 14, 2026, 10:23 AM UTC
Pricol Promoters to Sell 38.51% Stake in Autotech Unit to Warburg Pincus
Pricol said its board approved the sale of promoters’ entire 38.51% shareholding in Pricol Autotech Limited to Warburg Pincus.
M impact | MNA | Nov 14, 2026, 02:29 AM UTC
High Arctic Energy Services Agrees to Go-Private Sale to Newport Capital
High Arctic Energy Services entered into a definitive acquisition agreement and announced its intent to make a cash distribution to shareholders.
M impact | MNA | Nov 14, 2026, 01:01 AM UTC